FDA Inspection 965139 — Janssen Pharmaceuticals Inc.
The FDA completed an inspection of Janssen Pharmaceuticals Inc. on Jan 22, 2016 in Raritan, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jan 22, 2016
- Fiscal Year
- 2016
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Raritan, NJ (United States)
Additional Details
Postmarket Adverse Drug Experience (PADE)